New England Private Wealth Advisors LLC Tekla Life Sciences Investors Transaction History

New England Private Wealth Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$14.63 - $17.84 $192,838 - $235,149	-13,181 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.09 - $17.09 $1,946 - $2,204	129 Added 0.99%	13,181 $199,000
Q2 2019 Aug 08, 2019	BUY	$15.54 - $17.47 $1,802 - $2,026	116 Added 0.9%	13,052 $220,000
Q1 2019 May 02, 2019	BUY	$15.5 - $17.9 $1,550 - $1,789	100 Added 0.78%	12,936 $221,000
Q4 2018 Feb 12, 2019	BUY	$13.99 - $20.35 $2,014 - $2,930	144 Added 1.13%	12,836 $194,000
Q3 2018 Nov 13, 2018	BUY	$18.89 - $20.49 $1,851 - $2,008	98 Added 0.78%	12,692 $260,000
Q2 2018 Aug 13, 2018	BUY	$18.13 - $19.4 $1,813 - $1,939	100 Added 0.8%	12,594 $237,000
Q1 2018 May 04, 2018	BUY	$18.92 - $21.52 $1,873 - $2,130	99 Added 0.8%	12,494 $240,000
Q4 2017 Feb 13, 2018	BUY	$18.31 - $22.24 $1,904 - $2,312	104 Added 0.85%	12,395 $244,000
Q3 2017 Nov 09, 2017	BUY	$20.12 - $21.88 $247,294 - $268,927	12,291	12,291 $264,000

9.31M

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Get notified when there are updates to the investment portfolio of New England Private Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on New England Private Wealth Advisors LLC with notifications on news.